Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) – Global Trends & Forecast to 2018

Publisher Name :
Date: 17-Dec-2013
No. of pages: 258
Inquire Before Buying

The global microfluidicsmarket is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years.

The global microfluidics marketis categorized into materials, products, and applications segments. This report studies the market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on products, the pharmaceutical market is categorized into microfluidic chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The in-vitro diagnostics segment is further segmented into clinical diagnostics, Point-of-Care, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.

The rising demand for POC diagnostic devices, quick return on investments offered by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips will be the major drivers for this market.However, factors such as difficulty in incorporatingemerging microfluidic technologies into existing workflows and presence of complex and time consuming regulatory standards are hampering the market growth. Recent developments in drug delivery technologies such as microfluidic micropumps and microneedles are encouraging the growth of the microfluidics market. The in-vitro diagnostics segment commands the largest share of the microfluidics products market in 2013. However, the drug delivery devices segment is estimated to grow at the highestCAGR of 24.5% during the study period.

Factors such as reduced costs, driven by the low sample consumption, are demanding the adoption of microfluidic micropumps. The enhanced efficacy of transdermal delivery of macromolecules for treating various diseasesis a major factor driving the growth of themicroneedles market.The breakthrough discovery of injecting macromolecules transdermally is in turn favoring the growth of the API (Active Pharmaceutical Ingredient) market, which is boosting the adoption rate of microneedles.

Major players in the microfluidics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), DanaherCorporation (U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A majority of companies in the microfluidics market are from the U.S.

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) – Global Trends & Forecast to 2018

Table Of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Key Data Points From Secondary Sources
1.6.5 Assumptions

2 Executive Summary

3 Premium Insights
3.1 Global Microfluidics Market, A Snapshot (2013)
3.2 Market Dynamics
3.3 Microfluidics Market, By Industry
3.4 Microfluidics Market, By Applications
3.5 Geographic Analysis & Materials Market

4 Market Overview
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Rising Demand for Point-of-Care (Poc) Testing to Drive the Market
4.3.1.2 Quick Return  on Investments Helping In Cost Reductions
4.3.1.3 Microfluidic Chips Miniaturization Helps to Reduce Testing Time And Cost
4.3.2 Restraints
4.3.2.1 the Incorporation of Emerging Microfluidic Technology Into Existing Workflows Is Challenging
4.3.2.2 Complex And Time Consuming Regulatory Standards to Lengthen the Approval Process
4.3.3 Opportunities
4.3.3.1 Growing Asian Market
4.3.3.2 Shifting Trend towards Polymers Adoption
4.3.3.3 Expanding Applications of Drug Delivery Technologies
4.3.4 Trends
4.3.4.1 Increasing Number of Patent Applications
4.3.5 Challenges for Manufacturers
4.3.5.1 Geometrical Issues
4.3.5.2 Surface Chemistry Issues
4.3.6 Winning Imperatives
4.3.6.1 Standardization
4.3.6.2 Compatibility
4.4 Strategic Benchmarking
4.4.1 Technology Integration & Product Enhancement
4.4.1.1 Collaboration Between Fluidigm Corporation And Olink Bioscience
4.4.1.2 Agreement Between Agilent Technologies, Inc. And Caliper Life Sciences, Inc.
4.4.1.3 Agreement Between Perkinelmer And Genmark Diagnostics, Inc.
4.4.1.4 Collaboration Between Roche Diagnostics And Immatics Biotechnologies GMBH
4.4.1.5 Agreement Between Raindance Technologies And Myriad Genetics, Inc.

5 Microfluidics Market, By Material
5.1 Introduction
5.2 Polymer-Based Microfluidics
5.3 Glass-Based Microfluidics
5.4 Silicon-Based Microfluidics
5.5 Other Materials-Based (Paper & Ceramics) Microfluidics

6 Microfluidic Devices Market, By Industry
6.1 Introduction
6.2 Pharmaceuticals
6.2.1 Microfluidic Chips for Lab Analytics
6.2.1.1 Toxicity Screening
6.2.1.2 Proteomic Analysis
6.2.1.3 Gene Sequencing
6.2.1.4 Capillary Electrophoresis
6.2.2 Accurate Dispensing Devices
6.2.3 Microreactors for Drug Synthesis
6.3 In-Vitro Diagnostics
6.3.1 Clinical Diagnostics
6.3.2 Point-of-Care (Poc)
6.3.3 Environmental Testing
6.3.4 Industrial Testing
6.3.5 Agro Food Testing
6.4 Drug Delivery Devices
6.4.1 Inhaler Nozzles
6.4.2 Microneedles
6.4.3 Micropumps

7 Microfluidics Devices Market, By Applications
7.1 Introduction
7.2 Drug Delivery
7.3 Industrial & Environmental
7.4 Analysis (Toxicity Screening, Proteomic Analysis & Gene Sequencing)
7.5 Pharmaceutical & Life Science Research
7.6 Point of Care Diagnostics
7.7 Clinical & Veterinary Diagnostics

8 Geographic Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia
8.5 Rest of the World (ROW)

9 Competitive Landscape
9.1 Introduction
9.2 Mergers & Acquisitions
9.3 Agreements, Partnerships, Collaborations, & Joint Ventures
9.4 New Product Launches
9.5 Expansion
9.6 Approvals

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Abbott Laboratories, Inc.
10.2 Agilent Technologies
10.3 Perkinelmer, Inc.
10.4 Bartels Mikrotechnik GMBH
10.5 Scienion AG
10.6 Cepheid, Inc.
10.7 Fluidigm Corporation
10.8 Raindance Technologies
10.9 Becton, Dickinson And Company 1 Becton Drive
10.10 Bio-Rad Laboratories, Inc.
10.11 Biofluidix GMBH
10.12 Danaher Corporation
10.13 Johnson & Johnson
10.14 Life Technologies Corporation
10.15 Microfluidic Chipshop GMBH
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

Competitive Developments (2011-2013)

List of Tables

Table 1 Global Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 2 Global Microfluidic Materials Market: Revenue, By Type, 2011-2018 ($Million)
Table 3 Microfluidic Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 4 Polymer-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 5 Glass-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 6 Silicon-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 7 Paper & Ceramics-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 8 Microfluidics Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 9 Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 10 Microfluidics Pharmaceutical Products Market Revenue, By Geography, 2011-2018 ($Million)
Table 11 Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 12 Microfluidic Chips for Lab Analytics Market Revenue, By Geography, 2011-2018 ($Million)
Table 13 Microfluidic Chips for Toxicity Screening Market Revenue, By Geography, 2011-2018 ($Million)
Table 14 Microfluidic Chips for Proteomic Analysis Market Revenue, By Geography, 2011-2018 ($Million)
Table 15 Microfluidic Chips for Gene Sequencing Market Revenue, By Geography, 2011-2018 ($Million)
Table 16 Microfluidic Chips for Capillary Electrophoresis Market Revenue, By Geography, 2011-2018 ($Million)
Table 17 Microfluidic Accurate Dispensing Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 18 Microfluidic Microreactors for Drug Synthesis Market Revenue, By Geography, 2011-2018 ($Million)
Table 19 Microfluidic In-Vitro Diagnostics Market Revenue, By Products, 2011-2018 ($Million)
Table 20 Microfluidic In-Vitro Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 21 Microfluidic Clinical Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 22 Microfluidics Point of Care Market Revenue, By Geography, 2011-2018 ($Million)
Table 23 Microfluidic Environmental Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 24 Microfluidic Industrial Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 25 Microfluidic Agro Food Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 26 Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 27 Microfluidic Drug Delivery Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 28 Microfluidic Inhaler Nozzles Market Revenue, By Geography, 2011-2018 ($Million)
Table 29 Microfluidic Microneedles Market Revenue, By Geography, 2011-2018 ($Million)
Table 30 Microfluidic Micropumps Market Revenue, By Geography, 2011-2018 ($Million)
Table 31 Global Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 32 Microfluidics Drug Delivery Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 33 Microfluidics Industrial & Environmental Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 34 Microfluidics Analysis Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 35 Microfluidics Pharmaceutical & Life Science Research Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 36 Microfluidics Point of Care Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 37 Microfluidics Clinical & Veterinary Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 38 Global Microfluidics Market Revenue, By Geography, 2011-2018 ($Million)
Table 39 North America: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 40 North America: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 41 North America: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 42 North America: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 43 North America: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 44 North America: Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 45 North America: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 46 Europe: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 47 Europe: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 48 Europe: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 49 Europe: Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 50 Europe: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 51 Europe: Microfluidics Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 52 Europe: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 53 Asia: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 54 Asia: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 55 Asia: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 56 Asia: Microfluidics Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 57 Asia: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 58 Asia: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 59 Asia: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 60 ROW: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 61 ROW: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 62 ROW: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 63 ROW: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 64 ROW: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 65 ROW: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 66 ROW: Microfluidic Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 67 Mergers & Acquisitions, 2011-2013
Table 68 Agreements, Partnerships, Collaborations, & Joint Ventures, 2011-2013
Table 69 New Product Launches, 2011-2013
Table 70 Expansion, 2011-2012
Table 71 Approvals, 2013
Table 72 Life Technologies Corporation: Total Revenue, By Segment, 2010-2012 ($Million)

List of Figures

Figure 1 Market Crackdown & Data Triangulation Methodology for Microfluidics Market
Figure 2 Market forecasting Model
Figure 3 Research Output: 360o Validation
Figure 4 Global Microfluidics Market, By Products, 2013-2018 ($Million)
Figure 5 Global Microfluidics Market, 2013
Figure 6 Microfluidics Market Dynamics
Figure 7 Microfluidics Market, By Industry, 2013-2018
Figure 8 Microfluidics Market, By Applications, 2013 Vs 2018
Figure 9 Microfluidics Market: Geographic Analysis, 2013 ($Million)
Figure 10 Microfluidics Market Segmentation
Figure 11 Technology Adoption & Product Enhancement
Figure 12 Microfluidics Market: By Materials, 2011-2018 (Market Size & Growth Rates)
Figure 13 Global Polymers Market Comparison, 2013 Vs 2018
Figure 14 Microfluidics Market, By Products, 2013-2018
Figure 15 Microfluidics Products Market Revenue, By Industry – A Focus on Ivd (2013)
Figure 16 Global Microfluidics Market, By Applications, 2013-2018
Figure 17 Opportunity Matrix: Microfluidics Market, By Geography, 2013-2018
Figure 18 Key Growth Strategies in Microfluidics Market, 2011-2013
Figure 19 Abbott Laboratories, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 20 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012
Figure 21 Abbott Laboratories, Inc.: Business Revenue Mix, 2012
Figure 22 Abbott Laboratories, Inc.: Market Strategy, 2011-2013
Figure 23 Agilent Technologies: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 24 Agilent Technologies: Business Revenue Mix, 2012
Figure 25 Agilent Technologies: Market Strategy, 2010-2012
Figure 26 Perkinelmer, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 27 Perkinelmer, Inc.: Geographic Revenue Mix, 2012
Figure 28 Perkinelmer, Inc.: Business Revenue Mix, 2012
Figure 29 Perkinelmer, Inc.: Market Strategy, 2011-2012
Figure 30 Scienion AG: Market Strategy, 2012-2013
Figure 31 Cepheid, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 32 Cepheid, Inc.: Geographic Revenue Mix, 2012
Figure 33 Cepheid, Inc.: Business Revenue Mix, 2012
Figure 34 Cepheid, Inc.: Market Strategy, 2011-2013
Figure 35 Fluidigm Corporation: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 36 Fluidigm Corporation: Geographic Revenue Mix, 2012
Figure 37 Fluidigm Corporation: Business Revenue Mix, 2012
Figure 38 Fluidigm Corporation: Market Strategy, 2011-2013
Figure 39 Raindance Technologies: Market Strategy, 2011-2013
Figure 40 Becton, Dickinson And Company: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 41 BD Diagnostics: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 42 Becton, Dickinson And Company: Market Strategy, 2011-2013
Figure 43 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 44 Bio-Rad Laboratories, Inc.: Market Srategy, 2011-2013
Figure 45 Danaher Corporation: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 46 Danaher Corporation: Market Strategy, 2011-2013
Figure 47 Johnson & Johnson: Total Revenue, By Segment, 2010-2012 ($Milllion)
Figure 48 Johnson & Johnson: Diagnostics Franchise Revenue, 2010-2012 ($Million)
Figure 49 Johnson & Johnson: Market Strategy, 2011-2013
Figure 50 Life Technologies Corporation: Market Strategy, 2012-2013
Figure 51 Roche Holdings: Diagnostics Revenue, By Segment, 2010-2012 ($Million)
Figure 52 Roche Holdings: Diagnostics Revenue, By Geography, 2010-2012 ($Million)
Figure 53 Roche Holdings: Market Strategy, 2011-2013
Figure 54 Siemens Ag: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 55 Siemens Healthcare: Market Strategy, 2011-2013

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Aortic Stent Grafts – Current and Future Players
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 106
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Egypt Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government's increased emphasis on developing the pharmaceutical sector and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the c......
  • Indonesia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 142
    BMI View: Indonesia is one of the most promising markets for the pharmaceutical and healthcare companies in South East Asia. The country's large population, positive economic outlook and considerable disease burden bode well for growth in demand for drugs, medical devices and healthcare services. The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firm......
  • Moldova Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 93
    BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors, given the market's total size and its reliance on out-of-pocket payments. The country's economic outlook, which is defined by its relations with Russia and the EU, will play a significant role in how the market grows over the coming years. Headline Expenditure Projections ? Pharmaceuticals: MDL2.73bn (USD214mn) in 2013 to MDL2.9bn (USD226mn) in 2014; +5.7% in local currency terms and +5.4% in US doll......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 81
    BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcare sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spu......
  • 2014 Deep Research Report on Global and China Nalbuphine HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 121
    This is a professional and depth research report on Global and China Nalbuphine HCL industry. The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process,......
  • 2014 Deep Research Report on Global and China Naltrexone HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 138
    This is a professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market shar......
  • RNA Interference Screening Trends 2014
    Published: 27-Oct-2014        Price: US $2500 Onwards        Pages: 53
    Executive Summary This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on RNA interference (RNAi) screening and gene silencing carried out in October 2014. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update our previous report in siRNA screening (published September 2012). The questionnaire was compiled to meet the needs, requirements and interests of the RNAi screening vendo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs